Principles of Virology, Volume 2. S. Jane Flint

Читать онлайн книгу.

Principles of Virology, Volume 2 - S. Jane Flint


Скачать книгу
conclusively that mosquitos are the vectors for this disease. In retrospect, a mosquito-borne mode of transmission made sense, as the disease was predominantly found in warm and humid regions (e.g., Cuba, New Orleans) where mosquitos were, and remain, abundant. The members of this courageous team, perhaps the first true epidemiologists, are depicted in a dramatic 1939 painting (Fig. 1.1).

      The nature of the pathogen was established in 1901, when Reed and James Carroll injected diluted, filtered serum from the blood of a yellow fever patient into three healthy individuals. Two of the volunteers developed yellow fever, leading Reed and Carroll to conclude that a “filterable agent,” which we now know as yellow fever virus, was the cause of the disease. In the same year, a professor at the University of Havana attempted to produce immunity by exposing volunteers to mosquitos that were allowed to take a blood meal from an individual who showed signs of yellow fever. Of 19 volunteers, 8 contracted the disease, and 3 died. One of the deceased was Clara Louise Maass, a U.S. Army nurse. Maass’s story is of interest, as she had volunteered to be inoculated by infected mosquitos some time before, developed only mild symptoms, and survived. Her agreement to be infected a second time was to test if her earlier exposure provided protection from a subsequent challenge. This was a prescient idea, because at that time, virtually nothing was known about immune memory, which is the underlying principle of vaccines. Maass’s death prompted a public outcry and helped to end yellow fever experiments in human volunteers.

image

      BACKGROUND

       Mosquito control measures

      In the 1930s, a vaccine was developed for yellow fever virus that dramatically reduced the mortality associated with infection by this virus. Nevertheless, mosquitos remain a primary vector for transmission to humans of viruses for which vaccines do not exist, including Zika and chikungunya viruses, as well as the parasite that causes malaria. Consequently, mosquito control remains a major public health initiative worldwide, but these ubiquitous flying syringes pose a formidable challenge to such efforts.

      As mosquitos breed in standing water, reducing the prevalence of seemingly innocuous water traps such as old tires, inflatable pools, birdbaths, clogged gutters, and dis carded soda bottle caps can have a substantial impact on mosquito populations. However, such strategies are likely to be only moderately effective in humid, rainy, or swampy environments. Mosquito netting, with a maximum effective mesh size of 1.2 millimeters, has proven effective when hung over beds or incorporated into tents, and variants of this physical barrier were in effect even in the time of Cleopatra. Similarly, the widespread use of insecticides and repellents has reduced spread of mosquito-borne infections.

      Recently, more-creative strategies for mosquito control have been added to the anti-mosquito arsenal, including biocontrol, the use of natural enemies to manage mosquito populations. For example, certain fish, lizards, and other insects, such as dragonflies, feed on mosquito larvae. Their presence may thus help to limit populations naturally, although careless introduction of these species into mosquito-rich environments could de stabilize fragile ecosystems. Genetic manipulation of the mosquitos themselves is an active area of research: studies are ongoing to breed and then release large numbers of sterile male mosquitos; females that mate with a sterile male produce no offspring, thus reducing the next generation’s population size. An even more sophisticated control has been the development of genetically modified strains that require an antibiotic to develop beyond the larval stage. Modified males develop normally when provided with the antibiotic in nurseries. However, when the males are released into the wild and mate with normal females, the genetic vulnerability is transferred to future generations in an environment where the antibiotic is not available. As a result, progeny maturation cannot occur. In April 2014, Brazil’s National Technical Commission for Biosecurity approved the commercial release of a genetically modified mosquito, and the U.S. Food and Drug Administration is considering such measures in the United States.

      Other successful, and creative, mosquito control campaigns have been waged. For example, to reduce transmission of dengue virus, a community in Australia released millions of mosquitos infected with a bacterial species, Wolbachia, which prevents transmission of viruses such as dengue. When Wolbachia-infected mosquitos were released, they bred with others, infecting them with the bacteria and, in turn, preventing the infected mosquitos from transmitting viruses.

image

      Despite


Скачать книгу